180 Life Sciences Corp. - notizie pubblicate 234 - letture 8.926
180 LIFE SCIENCES CORP.
Life Sciences Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements Form 8 K
180 life sciences granted extension by nasdaq hearing panel to regain compliance with continued listing requirements palo alto, calif., july 2, 2024 -- 180 life sciences corp. (nas ...
180 LIFE SCIENCES CORP.
Failure to Satisfy Listing Rule - Form 8-K
Item 3.01notice of delisting or failure to satisfy a continued listing rule or standard; transfer of listing. as previously disclosed, on november 15, 2023, the listing qualificati ...
180 LIFE SCIENCES CORP.
Quarterly Earnings Document
United states securities and exchange commission washington, d. c. 20549 form 10-q (mark one) quarterly report pursuant to section 13 or 15(d) of the securities exchange act of 193 ...
180 LIFE SCIENCES CORP.
Quarterly Report for Quarter Ending March 31, 2024 (Form 10-Q)
United states securities and exchange commission washington, d. c. 20549 form 10-q (mark one) ☒quarterly report pursuant to section 13 or 15(d) of the securities exchange act of ...
180 LIFE SCIENCES CORP.
Failure to Satisfy Listing Rule - Form 8-K
Item 3.01. notice of delisting or failure to satisfy a continued listing rule or standard; transfer of listing. as previously disclosed, on november 15, 2023, the listing qualifica ...
180 LIFE SCIENCES CORP.
Management Change/Compensation - Form 8-K
Item 1.01 entry into a material definitive agreement. the information and description of the woody separation agreement, rothbard separation agreement, rothbard consulting agreemen ...
180 LIFE SCIENCES CORP.
Amendment to Annual Report - Form 10-K/A
United states securities and exchange commission washington, d.c. 20549 form 10-k/a (amendment no. 1) (mark one) ☒annual report pursuant to section 13 or 15(d) of the securities ...
180 LIFE SCIENCES CORP.
Quarterly Earnings Document
United states securities and exchange commission washington, d.c. 20549 form 10-k/a (amendment no. 1) (mark one) annual report pursuant to section 13 or 15(d) of the securities exc ...
180 LIFE SCIENCES CORP.
Notice of Effectiveness - Form EFFECT
Notice of effectiveness united states securities and exchange commission washington, d.c. 20549 notice of effectiveness effectiveness date: april 24, 2024 accession number: 0001213 ...
180 LIFE SCIENCES CORP.
Notice of Effectiveness - Form EFFECT
Notice of effectiveness united states securities and exchange commission washington, d.c. 20549 notice of effectiveness effectiveness date: april 24, 2024 accession number: 0001213 ...
180 LIFE SCIENCES CORP.
Post-Effective Amendment to Registration Statement - Form POS AM
As filed with the u.s. securities and exchange commission on april 19, 2024 registration no. 333-276796 united states securities and exchange commission washington, d.c. 20549 post ...
180 LIFE SCIENCES CORP.
Post-Effective Amendment to Registration Statement - Form POS AM
As filed with the u.s. securities and exchange commission on april 19, 2024 registration no. 333-272749 united states securities and exchange commission washington, d.c. 20549 post ...
180 LIFE SCIENCES CORP.
Material Event - Form 8-K
Item 4.01 changes in registrant's certifying accountant. on april 17, 2024, with the approval of the audit committee (the "audit committee") of the board of directors (th ...
180 LIFE SCIENCES CORP.
Initial Registration Statement for Employee Benefit Plan - Form S-8
As filed with the securities and exchange commission on april 17, 2024 registration no. 333- united states securities and exchange commission washington, d.c. 20549 form s-8 regist ...
180 LIFE SCIENCES CORP.
Quarterly Earnings Document
United states securities and exchange commission washington, d.c. 20549 form 10-k (mark one) ☒ annual report pursuant to section 13 or 15(d) of the securities exchange act of 193 ...
Per i consulenti finanziari
Abbiamo ricevuto 2.400 richieste di consulenza, pubblica il tuo profilo premium
per ricevere contatti e acquisire nuovi clienti